{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:44:54Z","timestamp":1768679094891,"version":"3.49.0"},"reference-count":22,"publisher":"Japan Neurosurgical Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.2176\/jns-nmc.2025-0011","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T22:07:40Z","timestamp":1755122860000},"page":"463-468","source":"Crossref","is-referenced-by-count":1,"title":["Stereotactic Functional Neurosurgery Combining Sedation and Awake Procedures Using Remimazolam Besylate and Flumazenil: A Technical Note"],"prefix":"10.2176","volume":"65","author":[{"given":"Kazuaki","family":"YAMAMOTO","sequence":"first","affiliation":[{"name":"Functional Neurosurgery Center, Shonan Fujisawa Tokushukai Hospital"},{"name":"Department of Neurosurgery, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"HIGUCHI","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Shonan Fujisawa Tokushukai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiya","family":"FUKUI","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Shonan Fujisawa Tokushukai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"WANIBUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Poon CC, Irwin MG. Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices. Br J Anaesth. 2009;103 (2):152-65. doi: 10.1093\/bja\/aep179","DOI":"10.1093\/bja\/aep179"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tsai ST, Chen TY, Lin SH, et al. Five-year clinical outcomes of local versus general anesthesia deep brain stimulation for parkinson&apos;s disease. Parkinsons Dis. 2019;2019:5676345. doi: 10.1155\/2019\/5676345","DOI":"10.1155\/2019\/5676345"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115 (2):274-83. doi: 10.1213\/ANE.0b013e31823f0c28","DOI":"10.1213\/ANE.0b013e31823f0c28"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Wei Y, Zhu M, Man Y, et al. Clinical study of flumazenil antagonizing remimazolam on nausea and vomiting after gynecologic day surgery. Drug Des Dev Ther. 2024;18:631-8. doi: 10.2147\/DDDT.S444313","DOI":"10.2147\/DDDT.S444313"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Yoshida A, Kurata S, Kida K, et al. Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil. JA Clin Rep. 2021;7 (1):14. doi: 10.1186\/s40981-021-00417-z","DOI":"10.1186\/s40981-021-00417-z"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Murata H, Yokoyama A, Hara T. Remimazolam and low-dose flumazenil for awake craniotomy. J Anesth. 2022;36 (6):789-90. doi: 10.1007\/s00540-022-03103-1","DOI":"10.1007\/s00540-022-03103-1"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Wu Q, Xu F, Wang J, et al. Comparison of remimazolam-flumazenil versus propofol for recovery from general anesthesia: a systematic review and meta-analysis. J Clin Med. 2023;12 (23):7316. doi: 10.3390\/jcm12237316","DOI":"10.3390\/jcm12237316"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Wesolowski AM, Zaccagnino MP, Malapero RJ, et al. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36 (9):1021-7. doi: 10.1002\/phar.1806","DOI":"10.1002\/phar.1806"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34 (4):543-53. doi: 10.1007\/s00540-020-02788-6","DOI":"10.1007\/s00540-020-02788-6"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Bateson AN. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des. 2002;8 (1):5-21. doi: 10.2174\/1381612023396681","DOI":"10.2174\/1381612023396681"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Yoshikawa H, Hosokawa M, Kashima Y, et al. Remimazolam tolerance in long-term benzodiazepine users: a case report of 2 cases. A A Pract. 2021;15 (5):e01460. doi: 10.1213\/XAA.0000000000001460","DOI":"10.1213\/XAA.0000000000001460"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Moss JH, Lanct\u00f4t KL. Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients. J Am Geriatr Soc. 1998;46 (8):1020-2. doi: 10.1111\/j.1532-5415.1998.tb02761.x","DOI":"10.1111\/j.1532-5415.1998.tb02761.x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Omichi C, Ayani N, Oya N, et al. Association between discontinuation of benzodiazepine receptor agonists and post-operative delirium among inpatients with liaison intervention: a retrospective cohort study. Compr Psychiatry. 2021;104:152216. doi: 10.1016\/j.comppsych.2020.152216","DOI":"10.1016\/j.comppsych.2020.152216"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155 (1):137-46. doi: 10.1016\/j.chest.2018.09.015","DOI":"10.1016\/j.chest.2018.09.015"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Pantos MM, Kennedy DR, Nemec EC. Remimazolam: a novel option for procedural sedation in high risk patients. J Pharm Pract. 2023;36 (1):149-54. doi: 10.1177\/08971900211027303","DOI":"10.1177\/08971900211027303"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88 (3):427-37.e6. doi: 10.1016\/j.gie.2018.04.2351","DOI":"10.1016\/j.gie.2018.04.2351"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166 (10):1338-44. doi: 10.1164\/rccm.2107138","DOI":"10.1164\/rccm.2107138"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Sivilotti ML. Flumazenil, naloxone and the &apos;coma cocktail&apos;. Br J Clin Pharmacol. 2016;81 (3):428-36. doi: 10.1111\/bcp.12731","DOI":"10.1111\/bcp.12731"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Klotz U, Kanto J. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788). Clin Pharmacokinet. 1988;14 (1):1-12. doi: 10.2165\/00003088-198814010-00001","DOI":"10.2165\/00003088-198814010-00001"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Sato T, Ando T, Ozeki K, et al. Prospective randomized controlled trial comparing anesthetic management with remimazolam besylate and flumazenil versus propofol during awake craniotomy following an asleep-awake-asleep method. J Neurosurg Anesthesiol. 2025;37 (1):40-6. doi: 10.1097\/ANA.0000000000000975","DOI":"10.1097\/ANA.0000000000000975"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021;81 (10):1193-201. doi: 10.1007\/s40265-021-01544-8","DOI":"10.1007\/s40265-021-01544-8"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Hirota K. Remimazolam: a new string to the TIVA bow. J Anesth. 2023;37 (3):335-9. doi: 10.1007\/s00540-023-03186-4","DOI":"10.1007\/s00540-023-03186-4"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/10\/65_2025-0011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:25:30Z","timestamp":1760761530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/10\/65_2025-0011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2025-0011","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"2025-0011"}}